FDA Approves Pfizer’s One-Time Gene Therapy BEQVEZ for Hemophilia B
Patients with moderate to severe hemophilia B can now take Pfizer’s BEQVEZ (fidanacogene elaparvovec-dzkt) with the approval of the FDA. Hemophilia B is an inherited bleeding disorder that affects more than 38,000 people…